关注
Luke A Jelen
Luke A Jelen
MRC Clinical Research Fellow, King's College London
在 kcl.ac.uk 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Single-dose psilocybin for a treatment-resistant episode of major depression
GM Goodwin, ST Aaronson, O Alvarez, PC Arden, A Baker, JC Bennett, ...
New England Journal of Medicine 387 (18), 1637-1648, 2022
3902022
Psychedelics in the treatment of unipolar mood disorders: a systematic review
JJH Rucker, LA Jelen, S Flynn, KD Frowde, AH Young
Journal of Psychopharmacology 30 (12), 1220-1229, 2016
1952016
Ketamine: a tale of two enantiomers
LA Jelen, AH Young, JM Stone
Journal of Psychopharmacology 35 (2), 109-123, 2021
1332021
Beyond static measures: A review of functional magnetic resonance spectroscopy and its potential to investigate dynamic glutamatergic abnormalities in schizophrenia
LA Jelen, S King, PG Mullins, JM Stone
Journal of Psychopharmacology 32 (5), 497-508, 2018
562018
Ketamine for depression
LA Jelen, JM Stone
International Review of Psychiatry, 1-32, 2021
472021
Expectancy in placebo-controlled trials of psychedelics: if so, so what?
M Butler, L Jelen, J Rucker
Psychopharmacology 239 (10), 3047-3055, 2022
422022
The anterior cingulate cortex as a key locus of ketamine’s antidepressant action
L Alexander, LA Jelen, MA Mehta, AH Young
Neuroscience & Biobehavioral Reviews 127, 531-554, 2021
422021
A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis
BJG Illingworth, DJ Lewis, AT Lambarth, K Stocking, JMN Duffy, LA Jelen, ...
Journal of psychopharmacology 35 (5), 501-511, 2021
372021
Historic psychedelic drug trials and the treatment of anxiety disorders
NM Weston, D Gibbs, CIV Bird, A Daniel, LA Jelen, G Knight, D Goldsmith, ...
Depression and Anxiety 37 (12), 1261-1279, 2020
352020
The opioid system in depression
LA Jelen, JM Stone, AH Young, MA Mehta
Neuroscience & Biobehavioral Reviews 140, 104800, 2022
252022
Functional magnetic resonance spectroscopy in patients with schizophrenia and bipolar affective disorder: Glutamate dynamics in the anterior cingulate cortex during a working …
LA Jelen, S King, CM Horne, DJ Lythgoe, AH Young, JM Stone
European Neuropsychopharmacology 29 (2), 222-234, 2019
252019
Inflammation, glutamate, and cognition in bipolar disorder type II: a proof of concept study
S King, LA Jelen, CM Horne, A Cleare, CM Pariante, AH Young, JM Stone
Frontiers in psychiatry 10, 381397, 2019
232019
Alternatives to ketamine in depression: state-of-the-art and future perspectives
LA Jelen, S King, JM Stone
Therapeutic Advances in Psychopharmacology 8 (3), 95-98, 2018
112018
Imaging brain Glx dynamics in response to pressure pain stimulation: a 1H-fMRS study
LA Jelen, DJ Lythgoe, JB Jackson, MA Howard, JM Stone, A Egerton
Frontiers in psychiatry 12, 681419, 2021
52021
The treatment of bipolar depression: current status and future perspectives
LA Jelen, AH Young
Current Behavioral Neuroscience Reports 7, 1-14, 2020
52020
New antidepressants: New day or false dawn?
LA Jelen, AH Young
European Neuropsychopharmacology 63, 1-3, 2022
42022
A transdiagnostic systematic review and meta-analysis of ketamine’s anxiolytic effects
H Hartland, K Mahdavi, LA Jelen, R Strawbridge, AH Young, L Alexander
Journal of Psychopharmacology 37 (8), 764-774, 2023
32023
New pharmacological interventions in bipolar disorder
MF Juruena, LA Jelen, AH Young, AJ Cleare
Bipolar Disorder: From Neuroscience to Treatment, 303-324, 2021
32021
Opioid Mechanisms and the Treatment of Depression
LA Jelen, AH Young, MA Mehta
22023
Variants in the zinc transporter-3 encoding gene (SLC30A3) in schizophrenia and bipolar disorder: Effects on brain glutamate – A pilot study
LA Jelen, MS Green, S King, AG Morris, X Zhang, DJ Lythgoe, AH Young, ...
22022
系统目前无法执行此操作,请稍后再试。
文章 1–20